Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-09-01 12:17:41 |
Versijas komentārs | |
Teksts |
Olainfarm will
Hold Second Quarter 2014 Investor Conference
Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its second quarter 2014 investor
conference webinar scheduled on September 10, 2014 at 16:00
(EET). Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
Salvis Lapiņš will inform about AS “Olainfarm” latest activities
and analyse the financial results of the second quarter 2014.
After the
presentation investors will be welcomed to ask
questions. Due to the limited webinar time, please send
in your questions in advance till September 9 to e-mail: ieva.kadakovska@nasdaqomx.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar For more
information on webinar service please visit:
http://www.nasdaqomxbaltic.com/en/products-services/webinars-3/
JSC
Olainfarm is one of the biggest pharmaceutical companies in Latvia
with more than 40 years of experience in production of medication
and chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 35 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia.
Information prepared
by:
Salvis
Lapins
JSC
“Olainfarm”
Member of the Management
Board
Rupnicu iela 5, Olaine,
Latvia, LV 2114
Phone: +371 6 7013
717
Fax: +371 6 7013
777
E-mail: slapinsh@olainfarm.lv
|
Pielikumi |
|